Ameriprise’s Faeth Therapeutics FTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.3M Buy
+682,494
New +$21.2M ﹤0.01% 1481

Other funds holding FTH

Ameriprise's FTH Position: Q3 2026 in Review

Ameriprise opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 682,494 shares worth $20.3M. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings.

79 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

  • Ameriprise held 682,494 shares of Faeth Therapeutics worth $20.3M as of Q3 2026.
  • Faeth Therapeutics was a new Ameriprise position in Q3 2026.
  • Faeth Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1481 holding.
  • 79 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.